Home › Funds › Twin Lakes Capital Management, LLC › ATHE
Twin Lakes Capital Management, LLC position in ATHE
ALTERITY THERAPEUTICS LTD · Health Care
Twin Lakes Capital Management, LLC reported holding 139,258 shares of ATHE (ALTERITY THERAPEUTICS LTD) in its Q2 2026 13F filing — a position valued at US$748K, representing 0.29% of its reported portfolio and ranking #47 among its reported holdings. Twin Lakes Capital Management, LLC has disclosed ATHE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Twin Lakes Capital Management, LLC's ATHE position evolved
Twin Lakes Capital Management, LLC first disclosed a stake in ATHE in Q3 2023 at 5,925 shares (US$15K). The position peaked in Q2 2026 at 139,258 shares, worth US$748K. Across 12 filings, Twin Lakes Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 139,258 shares valued at US$748K. Notable position changes include a 2250% increase in Q3 2025 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.92K | $14.69K | New |
| Q4 2023 | 5.92K | $14.75K | Hold |
| Q1 2024 | 5.92K | $12.27K | Hold |
| Q2 2024 | 5.92K | $10.72K | Hold |
| Q3 2024 | 5.92K | $7.78K | Hold |
| Q4 2024 | 5.92K | $19.61K | Hold |
| Q1 2025 | 5.92K | $20.44K | Hold |
| Q2 2025 | 5.92K | $24.22K | Hold |
| Q3 2025 | 139.26K | $523.61K | Add |
| Q4 2025 | 139.26K | $428.92K | Hold |
| Q1 2026 | 139.26K | $484.62K | Hold |
| Q2 2026 | 139.26K | $747.82K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ATHE and 13F data
ATHE (ALTERITY THERAPEUTICS LTD) is a Health Care company. 20 other funds we track also report a position in ATHE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Twin Lakes Capital Management, LLC
FAQ
How long has Twin Lakes Capital Management, LLC held ATHE?
Twin Lakes Capital Management, LLC has disclosed ATHE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Twin Lakes Capital Management, LLC's current position in ATHE?
As of Q2 2026, Twin Lakes Capital Management, LLC holds 139.26K shares of ATHE (ALTERITY THERAPEUTICS LTD), valued at $747.82K, representing 0.29% of its reported portfolio and ranking #47.
Has Twin Lakes Capital Management, LLC been buying or selling ATHE?
In the latest 13F filing (Q2 2026), Twin Lakes Capital Management, LLC held unchanged its position in ATHE. The position peaked in Q2 2026 at 139.26K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.